Navigation Links
Major HIV prevention trial in women to drop oral tenofovir arm
Date:9/28/2011

ective of the study was to answer questions about each of the approaches. Researchers don't know why the tenofovir tablet was not effective in the study's population predominately women in their 20's (and younger) who may or may not be married or in a committed relationship and are living in communities where HIV incidence is among the highest. Meanwhile, the team remains committed to completing the trial and to providing evidence on whether oral Truvada and/or tenofovir gel are effective in reducing the risk of HIV infection among young women.

The team is especially grateful to all of the VOICE participants, whose commitment to this trial has already helped in gaining insight about oral tenofovir tablets for preventing HIV among women. This information will have significant implications for a field that faces important decisions about the use of oral PrEP and in which particular populations it could have the most benefit.

No additional information about the independent DSMB's decision is available at this time. Once the study is completed, which is expected to be before the end of 2012, a full analysis of all data will be conducted.

A DSMB is an independent group of clinical research experts, statisticians, ethicists and often community representatives that provides additional oversight to a clinical study. A DSMB regularly reviews blinded data not available to the investigators or anyone else, while a clinical trial is in progress. Based on its review of interim data, a DSMB may, at any time, recommend that a trial, or part of a trial, be stopped if there are concerns about safety, compelling evidence for a product's effectiveness or if it becomes clear that the trial cannot show that a product is effective, a concept called futility.

Since the study began in September 2009, the NIAID Prevention Trials DSMB has conducted five periodic reviews of VOICE interim data. All reviews prior to the 16 September review indicated no conc
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-916-3315
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. One Month after Major Quake, Ongoing Crises for Haitian Children
2. Virginia House Majority Leader Morgan Griffith Sponsors Legislation Enabling Mobile Solution for Health Care SALEM, Va.
3. Major milestone achieved by our joint venture in China
4. Sunquest Announces Major Software Updates and Enhancements
5. MIT China joint venture is preparing a major commercial launch in July 2010
6. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
7. Highlights of major physics conference in Washington, D.C.
8. The Icebox of Atlanta Selected as T-shirt Vendor for 3 Major Divisions of American Cancer Society's Relay For Life
9. Majority of Marylanders without advance medical directives
10. Pew Report Finds Majority of States Fail to Ensure Proper Dental Health & Access to Care for Children
11. Americans Remain Split on Stalled Health Care Legislation, but Some Provisions Popular Among Majorities of Democrats, Independents and Republicans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... (PRWEB) April 24, 2015 Olive Fertility ... Olive Fertility co-founder and co-director, has been honoured for ... at the Evening of Hope Gala. , “We ... Dr. Albert Yuzpe, who has been at the forefront ... years,” says Jessica Séguin, Executive Director of Fertile Futures--a ...
(Date:4/24/2015)... April 24, 2015 With years of ... UGA is now proud to be partnered with a ... 16,000 animals a year. This partnership has brought new ... animals. , After providing an in-house payment plan ... Teaching Hospital (VMTH) wanted to increase financing options available ...
(Date:4/24/2015)... ON (PRWEB) April 24, 2015 ... safe, informed and legal access to medical cannabis, is ... are properly supported when advising patients. , NAC is ... Certificate Program. With a $250,000 grant, NAC will be ... program. , "Our goal is to help Canadians gain ...
(Date:4/24/2015)... “ Opera ” was featured on NewsWatch as ... and coolest technology products available to consumers. Andrew Tropeano, a ... and shared with viewers how this is the fastest way ... internet would not be in existence. But each web browser ... is no different. Celebrating their 20th anniversary this year, Opera ...
(Date:4/24/2015)... Telematics Berlin is the foremost Automotive Data event in ... content providers, associations and government bodies. From industry critical ... them converge in Berlin. This year’s start-up competition is ... currently at the forefront of Europe’s Silicon Valley but ... products, ParkTAG are one of the first social parking ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Co-founder, Dr Al Yuzpe, Recognized as a Pioneer in Fertility Preservation 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3
... , TUESDAY, Aug. 30 (HealthDay News) -- ... making informed health care decisions. The Agency for ... free, easy-to-understand pamphlets on six health-related topics, including the ... new Spanish-language guide on heart medications is part of ...
... News) -- Genes affect hereditary coronary heart disease risk but ... While it,s long been known that hereditary factors influence this ... genes or unhealthy lifestyle in the family, the Swedish researchers ... examined the health records of 80,214 adopted men and women ...
... show up to appointments with hypertension expert John Bisognano, M.D., ... will help lower their blood pressure. And like most physicians, ... good, or if they will cause any harm. ... number of people want to avoid standard pharmaceuticals," said Bisognano, ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, Aug. ... circulating in the blood which seems to be a harbinger ... The protein, cathepsin S, is strongly tied to the inflammatory ... heart disease. The authors of the new study, published ...
... HealthDay Reporter , MONDAY, Aug. 29 (HealthDay News) -- ... than patient preschoolers to grow into adults who lack ... is that there are some individuals who consistently presented ... Casey, a cognitive neuroscientist at the Sackler Institute for ...
... of improved management at the acute stage, the risk ... decreased by about 50% in the past 10 years. ... hospital, has resulted in improved survival and fewer recurrent ... try and further decrease long-term mortality in patients who ...
Cached Medicine News:Health News:U.S. Offers Health-Care Pamphlets in Spanish 2Health News:Beyond pills: Cardiologists examine alternatives to halt high blood pressure 2Health News:Beyond pills: Cardiologists examine alternatives to halt high blood pressure 3Health News:Blood Protein Might Signal Death Risk in Elderly 2Health News:'Gimme' Kids Often Grow Into 'Gimme' Adults 2Health News:'Gimme' Kids Often Grow Into 'Gimme' Adults 3Health News:What do patients receiving optimal medical therapy after a heart attack die from? 2
(Date:4/24/2015)... , April 24, 2015  Elekta has CE ... Monaco® treatment planning system , enabling European clinics to ... major treatment techniques including advanced 3D planning, IMRT, VMAT ... Monaco ® ... well improved workflow efficiency. Advancements in 3D planning as ...
(Date:4/23/2015)... Calif., April 23, 2015  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, today reported net income ... or $1.12 per diluted share.  Net income for the ... $0.56 per diluted share, and non-GAAP net income was ... Net sales for the quarter ended March 31, 2015 increased ...
(Date:4/23/2015)... - Health Canada is working with the Canadian manufacturers ... information regarding the risk of serious cardiovascular side effects ... used at high doses (at or above 2400 mg/day). ... Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) ... inflammation. The majority of ibuprofen products in ...
Breaking Medicine Technology:Elekta CE marks for Monaco v5.10 treatment planning system 2Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 2Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 3Information Update - New safety information for prescription-strength ibuprofen: Risk of heart attack and stroke at high doses 4
... Corporation ("Futuremed") (TSX: FMD) and Cardinal Health Canada Inc. ... Inc. (NYSE: CAH ), announced today that ... morning regarding Cardinal Health Canada,s proposed acquisition of all ... for CAD $8.15 per Common Share in cash (the ...
... WORTH, Texas, February 16, 2012 Medical ... in Fort Worth, Texas on March 14-15, 2012. In ... and MD&M East (Philadelphia, PA), MD&M Texas Conference is ... device design and development presented by experienced medtech industry ...
Cached Medicine Technology:Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 2Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 3Cardinal Health Canada Inc. Receives Competition Bureau Clearance for Acquisition of Futuremed 4Medical Design & Manufacturing Conference to be Launched in Texas in March 2012 2
... The CellTracks® Analyzer ... fluorescence microscope used to ... that are immunomagnetically selected ... consists of the CellTracks® ...
... These unique Acid Fast ... sputum smear with appropriate background ... containing a positive and negative ... Kinyoun (Cat. No. 353), Ziehl-Neelsen ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Medicine Products: